Home | UCSF Helen Diller Family Comprehensive Cancer Center

Aparajita Singh, MD, meets with patient Bill Shea, who was previously diagnosed with colon cancer. Photo by Deanne Fitzmaurice

UCSF Health Earns 30th Consecutive US News Best Hospitals Honor Roll

The 2026–2027 rankings recognize UCSF Medical Center with 10 specialties in the nation’s top 10, including two ranked No. 1.

Julian Hong, MD, stands outside at UCSF Mission Bay.

Shaping Our AI Future

Julian Hong, MD, discusses opportunities for AI in research and care, and why faculty and trainees will be essential to what comes next.

Gloved hands use a pipette to transfer liquid into a multiwell laboratory plate.

This Is How To Treat Cancer With Teacher Cells and Tumor Pieces

Lab-grown dendritic cells dressed with a sample of a patient’s tumor might someday train the immune system to fight cancer, study shows.

Two female scientists examine data on a digital screen in a lab.

Can Mini Organs Help Predict Breast Tumors’ Response to Therapy?

Combining patient-derived organoids with biomarker-associated treatment responses in breast cancer could lead to more personalized therapy.

Peder Larson, PhD, analyzes a brain scan in the MRI Control Room at UCSF Mission Bay.

From Digital Health to Drug Discovery: Cancer Projects Funded in RAP Spring 2026 Cycle

Nine investigators and teams were awarded grants in support of cancer research projects in the spring 2026 cycle of the UCSF Resource Allocation Program (RAP). Learn about their research.

A conceptual graphic illustration showing a scientist using petri dishes to test scientific samples, with snippets of data visualizations around him.

For Early Prostate Cancer ‘Active Surveillance’ Is Now #1 Choice

A UCSF-led study of more than 73,000 veterans shows a dramatic shift toward active surveillance for low-risk prostate cancer, reflecting efforts to reduce unnecessary treatment.

UCSF Study: Breast Cancer Is Rising Fast in Asian American Women

Younger women and those with advanced or aggressive forms of cancer are experiencing the largest increases.

Chu Lab Advances Precision Prostate and Bladder Cancer Therapy

Just three years after launching her laboratory at UCSF, urologic oncologist Carissa Chu, MD, is entering a new phase of growth.

Meet Four Graduate Student Researchers Advancing Cancer Science

Supported through the Molecular Oncology Program, four doctoral students are exploring new approaches to prostate cancer, leukemia, immunotherapy, and targeted drug delivery.